IPO watch

In European IPO news, French bioprocessing technology company Deinove S.A. last Friday registered its intention to pursue an IPO on the Alternext market of NYSE Euronext Paris.

Founded in 2006, the company is using Deinococcus species to develop technologies to make biofuels and antibiotics. It has raised €3.4 million ($4.5 million) from Truffle Capital, which owns more than 98% of the company...